AEROVATE THERAPEUTICS INC shareholders Q3 2023

AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

AEROVATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
OUP Management Co., LLC 603,762$8,193,05018.42%
TCG Crossover Management, LLC 2,201,274$29,871,2884.40%
Atlas Venture Life Science Advisors, LLC 2,039,249$27,672,6094.29%
Sofinnova Investments, Inc. 3,758,686$51,005,3693.22%
GREAT POINT PARTNERS LLC 1,091,233$14,808,0322.70%
RA Capital Management 8,263,982$112,142,2362.21%
Cormorant Asset Management, LP 1,561,696$21,192,2151.24%
Frazier Life Sciences Management, L.P. 1,204,867$16,350,0451.09%
Octagon Capital Advisors LP 497,370$6,749,3111.04%
Ghost Tree Capital, LLC 201,197$2,730,2430.90%
Nan Fung Group Holdings Ltd 47,936$650,4920.53%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$1,357,0000.41%
Orbimed Advisors 756,930$10,271,5400.22%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,187,618$16,115,9760.21%
Baker Brothers Advisors 1,963,479$26,644,4100.15%
Nantahala Capital Management 95,000$1,289,1500.11%
Eversept Partners, LP 50,242$681,7840.06%
Golden State Equity Partners 10,530$142,8920.04%
Parkwood LLC 20,653$2800.03%
Skandinaviska Enskilda Banken AB (publ) 50,866$6900.01%
External links

This page lists AEROVATE THERAPEUTICS INC's shareholders in Q3 2023. To view AEROVATE THERAPEUTICS INC's shareholder history, click here.